Chene Gardner
Director Financiero/CFO en SCORPEX, INC. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Kenneth Denos | M | 56 |
Synerteck, Inc.
| 25 años |
John Darrow Thomas | M | 47 | 12 años | |
Joseph Darold Caywood | M | 49 | - | |
Ian Jenkins | M | 40 | 7 años | |
Larson Elmore | M | - | - | |
David Baum | M | - | 8 años | |
Sean Martin | M | - | 8 años | |
Jun Liang | M | - | 5 años | |
Erwin Vahlsing | M | 67 | - | |
Anthony Roger Moore | M | 76 | 3 años | |
David Kugelman | M | - | - | |
Kevin Blanco | M | - | 12 años | |
Kyle M. Denos | M | - | - | |
Aubrey Oliver | M | 59 | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Mark Daniel Klok | M | 48 | 8 años | |
Juan-Carlos Ley | M | 53 | - | |
Scott Weissman | M | 46 | 1 años | |
Lee R. Rice | M | 80 | 2 años | |
Jim E. Frazier | M | 59 | - | |
Thomas McConnell | M | 61 | 2 años | |
Russell Bruce Adler | M | 63 | 1 años | |
Maryorie Michelle Rivas Batista | M | - | - | |
Norris R. Harris | M | 90 | - | |
Ralph Robert Catala | M | 65 | - | |
David Zimmerman | M | - | - | |
Lorne Kalisky | M | 54 | - | |
Corey Safran | M | 55 | - | |
George J. Edwards | M | 76 | 2 años | |
Whit Tehan | M | - | - | |
Joseph Toro | M | 38 | 1 años | |
Clayton B. Barlow | M | 52 |
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT.
Synerteck, Inc.
| 6 años |
Paul Douglas Major | M | 71 | 1 años | |
Randall S. Appel | M | - | - | |
Cyrus J. Boga | M | 56 | 3 años | |
Stephen Arne D. Greaves | M | 59 | - | |
Ruben Flores | M | 46 | 3 años | |
Douglas McFarland | M | 80 | - | |
Jackie Stephens | M | 58 | - | |
David J. Kovacs | M | 38 | - | |
Mirta Mojica de Quintero | M | - | - | |
Scott Bouslog | M | 62 | 1 años | |
Paul R. Donaldson | M | 79 | - | |
David Zirulnikoff | M | 49 | - | |
Walter Pera | M | 79 | 8 años | |
John D. Thomas | M | - |
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT. | - |
Kristina Hammonds | F | - | - | |
Sean E. Wagner | M | 51 | - | |
Robert K. Oldham | M | - |
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT. | - |
Michael K. Low | M | - |
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT. | - |
Daniel Reshef | M | 73 | - |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 50 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Chene Gardner
- Red Personal